Dr. Reddys Laboratories Ltd.

Dr. Reddy’s Laboratories has received an approval for the fund infusion by way of investment in preference shares of Dr. Reddy’s Laboratories SA, Switzerland, a wholly-owned subsidiary of the Company, up to an amount of GBP 500 million. The Board of Directors of the Company at its meeting held on July 27, 2024, has approved the same.

The fund will be used by the said wholly-owned subsidiary for the acquisition of Nicotinell and related brands by way of acquisition of all of the quotas of Northstar Switzerland SARL (Northstar Switzerland) incorporated in Switzerland owned by the Haleon Group.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.